A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

Condition:   Osteosarcoma Interventions:   Drug: Lenvatinib;   Drug: Ifosfamide;   Drug: Etoposide Sponsor:   Eisai Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials